Analysis – Page 94 – Goldea Capital

Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy

Written by Customer Service on June 4, 2026. Posted in Public Companies.

Designation is supported by an exploratory analysis from the Phase 1b study showing that some children with SMA previously treated with gene therapy who had suboptimal clinical status experienced slowing of neurodegeneration and clinically meaningful improvements in motor function following initiation of salanersen Salanersen is an investigational antisense oligonucleotide dosed once-yearly with the potential to be a meaningful therapy in the future SMA treatment landscapeCAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) announced today that the U.S. Food and Drug Administration (FDA) has granted salanersen Breakthrough Therapy Designation for the treatment of spinal muscular atrophy (SMA). Breakthrough Therapy designation is a process designed to expedite the development and review of drugs that...

Lleida.net showcases its digital identity and trust services at Money20/20 Europe

Written by Customer Service on June 4, 2026. Posted in Public Companies.

Lleidanet – Money20/20 EuropeLleida.net showcases its digital identity and trust services at Money20/20 EuropeMadrid and Amsterdam, 4 June.- Lleida.net (BME:LLN, EPA:ALLLN) took part this week in Amsterdam in Money20/20 Europe, one of the most influential events in the global fintech ecosystem, with the aim of strengthening the company’s presence as a leading brand in the digital identity and trust services industry. The company participated within the stand of ICEX Spain Trade and Investment, represented by Houda Akansous and José Manuel Linares. During the event, Lleida.net focused on its main lines of innovation, most notably its digital identity and digital wallet solutions (as key elements in the transformation of verification and onboarding processes), as well as the validation of digital certificates and centralised...

Ming Shing Group Holdings Limited Announces Resignation of Director and Re-designation of Chief Executive Officer

Written by Customer Service on June 4, 2026. Posted in Public Companies.

Hong Kong, June 04, 2026 (GLOBE NEWSWIRE) — Ming Shing Group Holdings Limited (the “Company” or “Ming Shing”) (NASDAQ: MSW), a Hong Kong-based company mainly engaged in wet trades works whose mission it is to become the leading wet trades works service provider in Hong Kong, announces a significant update in its board of directors (the “Board of Directors”). Ming Shing announces the resignation of Mr. Han YAN (“Mr. Yan”) as a director and chief executive officer of the Company and Mr. Dongjie LAO (“Mr. Lao”) as an independent director, chairman of the compensation committee, member of the nominating and corporate governance committee and member of the audit committee of the Company. Mr. Yan and Mr. Lao have indicated their resignation are for personal reasons and not due to any disagreement with the Company. Following Mr. Lao’s...

Arch Biopartners Featured in American Diabetes Association Thought Leadership Series at the 2026 Scientific Sessions in New Orleans

Written by Customer Service on June 4, 2026. Posted in Public Companies.

TORONTO, June 04, 2026 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Company will be featured in the 2026 American Diabetes Association Thought Leadership Series at their 86th scientific sessions in New Orleans June 5th–8th, 2026, which highlights programs, case studies, and best practices in diabetes in a set of short films. The Thought Leadership Film Series is a curated set of films profiling organizations active in research and innovation across the field. The series is designed to increase visibility for groups working to prevent and treat diabetes and to improve the lives of people affected by the disease. The film “Advancing Therapies for Diabetic Kidney Disease,” profiles the pioneering work at Arch Biopartners to build kidney therapeutics that addresses diabetic...

SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum

Written by Customer Service on June 4, 2026. Posted in Public Companies.

TEL AVIV, Israel, June 04, 2026 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) (“NeuroThera”), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, announced the closing of its acquisition of approximately 54% interest in CliniQuantum Ltd. (“CliniQuantum”). According to the share purchase agreement (the “SPA”), pursuant to which, NeuroThera acquired 56,375 ordinary shares of CliniQuatum (the “Transaction”), representing approximately 54% of the issued and outstanding ordinary shares of CliniQuantum, in consideration for the issuance of 56,600,000 common shares of NeuroThera (the “Consideration Shares”) to certain shareholders of CliniQuantum (the “Selling Shareholders”),...

Orion Reports FY 2026 Revenue of $86M and Adjusted EBITDA of $2.2M After Continued Growth in Q4; Reiterates FY 2027 Expectation of $95M-$97M in Revenue and Positive Adjusted EBITDA

Written by Customer Service on June 4, 2026. Posted in Earnings Releases And Operating Results.

MANITOWOC, Wis., June 04, 2026 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle (EV) charging stations and maintenance services solutions, today reported improved results for its fiscal 2026 fourth quarter (Q4’26) and full fiscal year 2026 (FY’26) ended March 31, 2026. Orion’s Q4’26 revenue was $25.7M versus $20.9M in Q4’25 — a 23% increase — while Q4’26 gross margin was up by 950 basis points year-over-year, at 37.0% versus 27.5% in Q4’25. The Company improved its net loss in Q4’26 to $1.5M, compared to a net loss of $2.9M in Q4’25. The Company achieved Q4’26 adjusted EBITDA of $0.8M — marking its sixth consecutive quarter of positive adjusted EBITDA – compared to adjusted EBITDA of $0.2M in Q4’25. For the full fiscal year of FY’26, Orion’s...

Microchip Technology Receives U.S. Export License to Expand Advanced FPGA Development in Armenia

Written by Customer Service on June 4, 2026. Posted in Public Companies.

License supports the company’s growing footprint in Armenia as the region emerges as a hub for advanced semiconductor development YEREVAN, Armenia, June 04, 2026 (GLOBE NEWSWIRE) — Microchip Technology’s (Nasdaq: MCHP) Armenian office has received approval from the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) for an export license authorizing the use of advanced technology under Export Control Classification Number (ECCN) 3E001 and related high‑performance hardware under ECCN 3A001.a.7.b. Such authorization requires companies to demonstrate rigorous compliance with U.S. export regulations, including clear definition of permitted end uses, controlled access to sensitive technology and robust internal compliance safeguards. The license enables Microchip to securely and responsibly develop advanced semiconductor...

US Capital Global Announces $1.05 Billion in Recently Closed Financing and Advisory Transactions

Written by Customer Service on June 4, 2026. Posted in Mergers And Acquisitions.

Sixteen recently completed transactions across healthcare, technology, real estate, media, hospitality, and alternative assets highlight the firm’s ability to structure and execute complex debt, equity, M&A, and strategic advisory mandates across diverse market sectors.Selected RecentTransactionsThe selected transaction tombstones highlight a cross-section of US Capital Global’s recently completed financing and advisory work, representing mandates across healthcare, technology, real estate, media, hospitality, consumer products, advanced manufacturing, and alternative assets. Together, these transactions illustrate the firm’s ability to structure and execute customized debt, equity, M&A, and strategic advisory solutions for middle-market companies, sponsors, and investors across a wide range of capital needs and market...

Leading Independent Proxy Advisory Firm Recommends G2 Goldfields’ Shareholders Vote FOR the Arrangement With G Mining

Written by Customer Service on June 4, 2026. Posted in Mergers And Acquisitions.

TORONTO, June 04, 2026 (GLOBE NEWSWIRE) — G2 Goldfields Inc. (“G2” or the “Company”) (TSX:GTWO; OTCQX:GUYGF) is pleased to announce that Institutional Shareholder Services Inc. (“ISS”), a leading independent proxy advisory firm, has recommended that G2 shareholders vote “FOR” the plan of arrangement (the “Arrangement”) with G Mining Ventures Corp. (“GMIN”) to be approved at the upcoming special meeting of shareholders (the “Meeting”) to be held on Tuesday June 16, 2026 at 10:00 a.m. (Toronto Time). ISS commented “The merger and connected spin-out transaction makes strategic sense as shareholders will henceforth hold shares of two separate publicly listed companies. The board undertook a robust strategic review process, obtained multiple fairness opinions, and the independent special committee negotiated an implied value transfer...

Auddia Announces First Build Milestones for McCarthy Finney Operating System (MCFN-OS) Ahead of Proposed Merger Close

Written by Customer Service on June 4, 2026. Posted in Mergers And Acquisitions.

Company engages platform architect to begin construction of AI-native, web3-enabled Operating System MCFN-OS designed to deliver agentic AI, a shared institutional memory, and chat-first workflow automation across portfolio First production module targeted for Q3 2026 release BOULDER, Colo., June 04, 2026 (GLOBE NEWSWIRE) — Auddia Inc. (NASDAQ: AUUD) (“Auddia” or the “Company”), an AI first technology company that has built a proprietary AI platform for audio identification and classification to reinvent how consumers engage with audio and how artists get discovered, today announced the first concrete development milestones for the McCarthy Finney Operating System (MCFN-OS), the AI-native, Web3-enabled operating platform that will power McCarthy Finney upon the closing of the proposed merger between Auddia Inc. and Thramann Holdings,...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals